BioTelemetry

The healthcare industry is at a critical juncture, where every effort is being made to increase the effectiveness of care, while decreasing the financial burden on our system. With the introduction of BioTelemetry, we aim to lead in the advancement of mobile health monitoring by providing unmatched products and services to help healthcare professionals track and diagnose patients in a more efficient, accurate, and cost-effective manner. In April 2013, our predecessor company, CardioNet, Inc. (NASDAQ: BEAT), announced plans to adopt a holding company structure to more effectively facilitate our ongoing growth plans. With this change, our strategy is to achieve sustained long-term growth by solidifying our leadership position in remote cardiac monitoring, building a leading research services business, and identifying markets that would benefit from the application of our wireless platform and proprietary technology. We currently have four subsidiaries: CardioNet & Mednet- cardiac medical device & monitoring services, Braemar- cardiac manufacturing, Cardiocore- cardiac clinical research.
Type
Public
HQ
Malvern, US
Founded
2013
Size (employees)
938 (est)
Website
gobio.com
BioTelemetry was founded in 2013 and is headquartered in Malvern, US

BioTelemetry Office Locations

BioTelemetry has an office in Malvern
Malvern, US (HQ)
102 1000 Cedar Hollow Rd

BioTelemetry Financials and Metrics

BioTelemetry Financials

BioTelemetry's revenue was reported to be $208.3 m in FY, 2016
USD

Revenue (Q2, 2017)

58.1 m

Gross profit (Q2, 2017)

36 m

Gross profit margin (Q2, 2017), %

62%

Net income (Q2, 2017)

1.7 m

EBIT (Q2, 2017)

4.4 m

Market capitalization (13-Nov-2017)

824.5 m

Cash (30-Jun-2017)

26.9 m

EV

822.3 m
BioTelemetry's current market capitalization is $824.5 m.
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

119 m111.5 m129.5 m166.6 m178.5 m208.3 m

Revenue growth, %

(6%)16%29%7%17%

Cost of goods sold

6.2 m5.1 m4.9 m73.1 m72 m78.9 m

Gross profit

112.8 m106.4 m124.6 m93.5 m106.6 m129.5 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

31.9 m37.2 m42.7 m43.1 m43.4 m44.8 m43.5 m48.6 m52.7 m53.1 m55.9 m58.1 m

Cost of goods sold

12.6 m15.5 m19 m19.4 m18.2 m18.1 m17.2 m18 m19.8 m20.2 m23 m22.2 m

Gross profit

19.2 m21.6 m23.6 m23.7 m25.2 m26.7 m26.3 m30.6 m32.9 m32.9 m32.9 m36 m

Gross profit Margin, %

60%58%55%55%58%60%61%63%62%62%59%62%
USDY, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016

Cash

18.7 m18.3 m18.3 m22.2 m20 m19 m23.1 m

Inventories

2.4 m2.4 m1.5 m5.2 m

Current Assets

44.3 m49.5 m47 m59.6 m

PP&E

18.8 m21.7 m25.6 m25.8 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

21 m12 m13.5 m12.2 m12.3 m14.8 m15.5 m22.8 m25.4 m32.3 m25.1 m26.9 m

Inventories

3.4 m3 m3 m2.6 m3 m3.2 m2.8 m2.9 m3.5 m3.8 m4.3 m4.1 m

Current Assets

46 m40.8 m41.8 m41.9 m42.3 m43.5 m45.2 m51.7 m59 m68.3 m64 m65.9 m

PP&E

17.7 m25 m29.1 m29 m21.4 m23.8 m25 m26.3 m26.3 m26.3 m26.4 m26.7 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(7.3 m)(9.8 m)7.4 m53.4 m

Depreciation and Amortization

12.3 m12.6 m12.5 m14.3 m

Accounts Receivable

(4.6 m)(13 m)(7.7 m)

Inventories

340 k299 k188 k(753 k)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Net Income

(7.3 m)(4.1 m)(8.1 m)(8.1 m)(69 k)2.1 m4.6 m4 m8.3 m12.4 m196 k1.9 m

Depreciation and Amortization

9.5 m2.8 m6 m9.2 m3 m6 m9.1 m3.3 m6.9 m10.6 m3.7 m7.5 m

Accounts Receivable

(3.8 m)(5 m)(7.6 m)(11.2 m)(3 m)(4 m)(6.8 m)(2.9 m)

Inventories

(520 k)(104 k)(104 k)307 k(456 k)(640 k)(241 k)(487 k)(786 k)(1.2 m)810 k845 k
Y, 2017

EV/EBIT

187.4 x

EV/CFO

76.6 x

Financial Leverage

1.4 x
Show all financial metrics

BioTelemetry Operating Metrics

FY, 2015FY, 2016

Patents (foreign)

81111

Patents Issued

115160

Trademarks

1722

Patents (US)

3449
Show all operating metrics

BioTelemetry Market Value History

BioTelemetry's Web-traffic and Trends

BioTelemetry News and Updates

Latest News on - Prescribed Health Apps Global Market Trends & Opportunities

Wiseguyreports.Com Publish New Market Research Report On -“Prescribed Health Apps 2017 Global Market – Key Players, Size, Trends, Opportunities, Growth- Analysis to 2021” Posted via Industry Today. Follow us on Twitter @IndustryToday

BioTelemetry Company Life and Culture

You may also be interested in